The goal of this study is to determine the feasibility and acceptability of an intervention (Rapid PrEP Access) providing people who inject drugs (PWID) immediate access to PrEP prescriptions through same-day human immunodeficiency virus (HIV) self-testing, HIV viral load dried blood spot (DBS) testing and on-site prescriptions at a Mobile Prevention Services Van.
Aim 1: To implement 'Rapid PrEP Access' at a Mobile Prevention Services Van to increase uptake of PrEP among PWID.
Aim 2: To determine the feasibility and acceptability of 'Rapid PrEP Access' at a Mobile Prevention Services Van.
At the current time the Victory program in collaboration with Boston Medical Center (BMC) and the Department of Public Health (DPH) offers HIV testing to its clients; however, this HIV testing is performed through laboratory-based testing which requires a blood draw. PrEP is not currently offered through the Victory program. As part of this study, HIV testing in the form of HIV self-testing (as opposed to laboratory-based testing offered through BMC/DPH) will be offered as well as HIV PrEP for individuals who test negative on HIV self-test and are interested in PrEP. The investigators will also perform HIV viral load dried blood spot (DBS) testing to confirm the absence of HIV. Results for confirmatory DBS testing will be available after enrollment.
HIV PrEP and HIV self-testing are FDA approved and CDC recommended, but their uptake in the community among individuals who are at-risk has been low. Therefore, the goal of this pilot study is to increase uptake by bringing these measures to the communities that are most in need. The study will offer immediate access to PrEP through an intervention that utilizes point-of-care HIV self-testing, HIV DBS testing for viral load quantification and confirmatory testing, followed by evaluation for PrEP and on-site PrEP initiation by a nurse practitioner for eligible patients. Participants will also have additional PrEP-related testing that are part of regular clinical care performed at Victory Program. These tests include standard sexually transmitted infections (STI) testing (ie. syphilis, chlamydia, gonorrhea, hepatitis B & C) and renal function testing.
A baseline assessment followed by evaluations at 3 and 6 months will be obtained on study participants. After completing baseline assessments at the mobile van, study staff will encourage individuals to follow-up at BMC for longitudinal clinical care.
Has No Placebo